Immunologic impairment after long-term remission in splenectomized patients with Hodgkin's disease.
Loven
D
D
Institute of Oncology, Beilinson Medical Center, Petah Tikva, Israel.
Pick
A I
AI
Weiss
H
H
Duczyminer-Kahana
M
M
Lurie
H
H
D000293:Adolescent; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000276:immunology* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007108:Immune Tolerance; D007159:Immunologic Tests; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D013156:Splenectomy; D013601:T-Lymphocytes